BIOMAT Database Logo BIOMAT Database Logo

Behavioral sensitization following subchronic apomorphine treatment--possible neurochemical basis. 1990

D M Vaughn, and J A Severson, and J J Woodward, and P K Randall, and W H Riffee, and S W Leslie, and R E Wilcox
Scott-Ritchey Research Program School of Veterinary Medicine, Auburn University, AL 36849.

Subchronic treatment with the dopamine agonist apomorphine produces a sensitization to the stereotypic effects of subsequent apomorphine challenge. The present study investigated the effects of this subchronic treatment on apomorphine induced stereotypic behavior and striatal dopamine synthesis, release, metabolism, and D2 receptor binding. The pretreatment, which enhanced the behavioral response to apomorphine challenge, also elevated basal dopamine synthesis and metabolism, but left the ability of a challenge dose of apomorphine to inhibit dopamine synthesis and metabolism unaltered. Thus, ongoing dopamine synthesis and extracellular levels of metabolites would be higher following apomorphine challenge in animals treated subchronically with the agonist. In contrast, neither synaptosomal dopamine release in response to depolarizing stimuli nor the density of D2 dopamine receptors was altered by the treatment. Overall, the results suggest that, while we did not find evidence of autoreceptor desensitization per se, apomorphine treatment may result in enhanced extracellular dopamine levels following dopamine agonist challenge to provide a greater stimulation of an intact dopamine receptor system.

UI MeSH Term Description Entries
D008297 Male Males
D011954 Receptors, Dopamine Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells. Dopamine Receptors,Dopamine Receptor,Receptor, Dopamine
D003342 Corpus Striatum Striped GRAY MATTER and WHITE MATTER consisting of the NEOSTRIATUM and paleostriatum (GLOBUS PALLIDUS). It is located in front of and lateral to the THALAMUS in each cerebral hemisphere. The gray substance is made up of the CAUDATE NUCLEUS and the lentiform nucleus (the latter consisting of the GLOBUS PALLIDUS and PUTAMEN). The WHITE MATTER is the INTERNAL CAPSULE. Lenticular Nucleus,Lentiform Nucleus,Lentiform Nuclei,Nucleus Lentiformis,Lentiformis, Nucleus,Nuclei, Lentiform,Nucleus, Lenticular,Nucleus, Lentiform,Striatum, Corpus
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001058 Apomorphine A derivative of morphine that is a dopamine D2 agonist. It is a powerful emetic and has been used for that effect in acute poisoning. It has also been used in the diagnosis and treatment of parkinsonism, but its adverse effects limit its use. Apokinon,Apomorphin-Teclapharm,Apomorphine Chloride,Apomorphine Hydrochloride,Apomorphine Hydrochloride Anhydrous,Apomorphine Hydrochloride, Anhydrous,Apomorphine Hydrochloride, Hemihydrate,Britaject,Apomorphin Teclapharm
D013239 Stereotyped Behavior Relatively invariant mode of behavior elicited or determined by a particular situation; may be verbal, postural, or expressive. Behavior, Stereotyped,Behaviors, Stereotyped,Stereotyped Behaviors
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D017448 Receptors, Dopamine D2 A subfamily of G-PROTEIN-COUPLED RECEPTORS that bind the neurotransmitter DOPAMINE and modulate its effects. D2-class receptor genes contain INTRONS, and the receptors inhibit ADENYLYL CYCLASES. Dopamine D2 Receptors,Dopamine-D2 Receptor,D2 Receptors, Dopamine,Dopamine D2 Receptor,Receptor, Dopamine-D2
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

D M Vaughn, and J A Severson, and J J Woodward, and P K Randall, and W H Riffee, and S W Leslie, and R E Wilcox
Neurochemical correlates of behavioral sensitization following repeated apomorphine treatment: assessment of the role of D1 dopamine receptor stimulation.
June 1993, Synapse (New York, N.Y.),
D M Vaughn, and J A Severson, and J J Woodward, and P K Randall, and W H Riffee, and S W Leslie, and R E Wilcox
Behavioral and neurochemical modifications induced by apomorphine treatment.
May 1989, Neuroscience letters,
D M Vaughn, and J A Severson, and J J Woodward, and P K Randall, and W H Riffee, and S W Leslie, and R E Wilcox
Behavioral and neurochemical sensitization following cocaine self-administration.
June 1994, Psychopharmacology,
D M Vaughn, and J A Severson, and J J Woodward, and P K Randall, and W H Riffee, and S W Leslie, and R E Wilcox
Behavioral and neurochemical effects of apomorphine in the cat.
June 1982, European journal of pharmacology,
D M Vaughn, and J A Severson, and J J Woodward, and P K Randall, and W H Riffee, and S W Leslie, and R E Wilcox
Neurochemical and behavioral effects of acute and chronic treatment with apomorphine in rats.
February 1991, Neuropharmacology,
D M Vaughn, and J A Severson, and J J Woodward, and P K Randall, and W H Riffee, and S W Leslie, and R E Wilcox
Behavioral and neurochemical sensitization to amphetamine following early postnatal administration of methylmercury (MeHg).
January 2007, Neurotoxicology,
D M Vaughn, and J A Severson, and J J Woodward, and P K Randall, and W H Riffee, and S W Leslie, and R E Wilcox
Behavioral and neurochemical effects induced by subchronic l-deprenyl administration.
November 1997, Pharmacology, biochemistry, and behavior,
D M Vaughn, and J A Severson, and J J Woodward, and P K Randall, and W H Riffee, and S W Leslie, and R E Wilcox
MDMA elicits behavioral and neurochemical sensitization in rats.
June 1998, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
D M Vaughn, and J A Severson, and J J Woodward, and P K Randall, and W H Riffee, and S W Leslie, and R E Wilcox
Persistent behavioral and neurochemical sensitization to an acute injection of methamphetamine following unpredictable stress.
October 2014, Behavioural brain research,
D M Vaughn, and J A Severson, and J J Woodward, and P K Randall, and W H Riffee, and S W Leslie, and R E Wilcox
Regional neurochemical profile following development of apomorphine-induced reinforcement.
July 2012, Pakistan journal of pharmaceutical sciences,
Copied contents to your clipboard!